Figures and Tables

From the following article:

Ligand-targeted therapeutics in anticancer therapy

Theresa M. Allen

Nature Reviews Cancer 2, 750-763 (October 2002)

doi:10.1038/nrc903

Figure 1 - Ligand-targeted therapeutics in anticancer therapy

Figure 1

Internalization of LTTs and the 'bystander effect'.

Figure 2 - Ligand-targeted therapeutics in anticancer therapy

Figure 2

Antibodies and antibody fragments.

Figure 3 - Ligand-targeted therapeutics in anticancer therapy

Figure 3

Examples of the main classes of LTT.

Table 1 - Ligand-targeted therapeutics in anticancer therapy

Table 1

Some ligands that have been used in LTTs

Table 2 - Ligand-targeted therapeutics in anticancer therapy

Table 2

Radioimmunotherapeutics in the clinic

Table 3 - Ligand-targeted therapeutics in anticancer therapy

Table 3

Immunotoxins in the clinic

Table 4 - Ligand-targeted therapeutics in anticancer therapy

Table 4

New approaches to immunotoxins